153 related articles for article (PubMed ID: 32220419)
1. Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care.
McLean L; Whittle JR; Graham J; Ismail H; Lichtenstein M; Hicks RJ; McNally O; Herschtal A; Rosenthal M; Rischin D; Hamilton A
Gynecol Oncol; 2020 Jun; 157(3):793-798. PubMed ID: 32220419
[TBL] [Abstract][Full Text] [Related]
2. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
[TBL] [Abstract][Full Text] [Related]
3. Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers.
Samani A; Bennett R; Eremeishvili K; Kalofonou F; Whear S; Montes A; Kristeleit R; Krell J; McNeish I; Ghosh S; Tookman L
ESMO Open; 2022 Apr; 7(2):100401. PubMed ID: 35227967
[TBL] [Abstract][Full Text] [Related]
4. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
[TBL] [Abstract][Full Text] [Related]
6. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.
Ainsworth NL; Marshall A; Hatcher H; Whitehead L; Whitfield GA; Earl HM
Ann Oncol; 2012 Jul; 23(7):1845-53. PubMed ID: 22104575
[TBL] [Abstract][Full Text] [Related]
8. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
Graciano Vera N; Pino Villarreal L; Ureña Vargas J
Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
[TBL] [Abstract][Full Text] [Related]
10. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
[TBL] [Abstract][Full Text] [Related]
11. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
Morrow A; Garland C; Yang F; De Luna M; Herrington JD
J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
[TBL] [Abstract][Full Text] [Related]
12. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.
Quinton A; Lewis P; Ali P; Morgan C; Bertelli G
Med Oncol; 2013; 30(3):661. PubMed ID: 23864250
[TBL] [Abstract][Full Text] [Related]
13. Assessment of renal function before contrast media injection: right decisions based on inaccurate estimates.
Ptáčník V; Zogala D; Skibová D; Jiskrová H; Trnka J; Tesař V; Ryšavá R; Šámal M
Eur Radiol; 2019 Jun; 29(6):3192-3199. PubMed ID: 30413953
[TBL] [Abstract][Full Text] [Related]
14. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
[TBL] [Abstract][Full Text] [Related]
16. Optimizing carboplatin dosing by an improved prediction of carboplatin clearance using a CT-enhanced estimate of renal function.
Molenaar-Kuijsten L; Pieters TT; Veldhuis WB; Moeskops P; Rijkhorst EJ; Dorlo TPC; Beijnen JH; Steeghs N; Rookmaaker MB; Huitema ADR
Br J Clin Pharmacol; 2023 Oct; 89(10):3016-3025. PubMed ID: 37194167
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin.
Jennings S; de Lemos ML; Levin A; Murray N
J Oncol Pharm Pract; 2010 Jun; 16(2):113-9. PubMed ID: 19578094
[TBL] [Abstract][Full Text] [Related]
18. Chromium-51 ethylenediamine tetraacetic acid glomerular filtration rate: a better predictor than glomerular filtration rate calculated by the Cockcroft-Gault formula for renal involvement in systemic lupus erythematosus patients.
Godfrey T; Cuadrado MJ; Fofi C; Abbs I; Khamashta MA; Nunan T; Hughes GR
Rheumatology (Oxford); 2001 Mar; 40(3):324-8. PubMed ID: 11285381
[TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
[TBL] [Abstract][Full Text] [Related]
20. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
